Search Tag: prostate cancer

2015 17 May

Researchers at University of Gothenburg (Sweden) say a new method that combines a traditional PSA test with an MRI can detect a significantly greater number of prostate cancer cases and improve diagnostic accuracy. They conducted the study as part of the largest international research project on prostate cancer. Based on 384 Swedish subjects, the study...Read more

2015 25 Mar

Early results from the Göteborg randomised screening trial show that the use of MRI alongside conventional prostate cancer screening may offer improved cancer detection and may help in avoiding unnecessary biopsies. The Göteborg Trial is the Swedish arm of the European Randomised Study of Screening for Prostate Cancer, the largest randomised prostate...Read more

2015 12 Mar

A study published online in JAMA Oncology has found an association between high rates of inappropriate imaging for breast cancer and prostate cancer, diseases for which specialist physicians do not overlap. The revelation suggests that regional infrastructure and culture may contribute to the sometimes inappropriate utilisation of healthcare resources,...Read more

2015 11 Mar

A pilot clinical study involving nine prostate cancer patients has compared standard MRI with a new clinical imaging technique that has the ability to identify less severe forms of the disease, potentially saving patients unnecessary treatment. The new technique generates more precise images so that surgeons are better able to determine the extent...Read more

2015 30 Jan

A large-scale study shows that targeted biopsy using new fusion technology that combines magnetic resonance imaging (MRI) with ultrasound is more effective than standard biopsy in detecting high-risk prostate cancer. Researchers found that 30 percent more high-risk prostate cancers were diagnosed with targeted fusion-guided biopsy than with standard...Read more

2015 08 Jan

A new imaging technique that measurably improves upon current prostate imaging could have significant implications for how patients with prostate cancer are ultimately treated. The new method called restriction spectrum imaging-MRI (RSI-MRI) was developed by researchers from the University of California, San Diego School of Medicine, and University...Read more

2014 05 Aug

The company marketing Ablatherm Integrated Imaging High Intensity Focused Ultrasound (HIFU), used to treat low-risk prostate cancer, has failed to get the nod of U.S. Food and Drug Administration (FDA) on its premarket approval application. HIFU, which has been used in other countries for about 15 years, is marketed in Europe by EDAP TMS, a French...Read more

2013 14 Nov

  During the recently held EAU 13th Central European Meeting (CEM) in Prague, Czech Republic, the study entitled ‘Using Magnetic Resonance Imaging-Ultrasound (MRIUS)- guided prostate biopsy has high sensitivity to detect prostate abnormalities compared with transrectal ultrasonography (TRUS biopsy) of MRI positive findings’ won the first prize from...Read more